HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
J Tol Selected Research
J Tol Research Topics
Disease
6
Colorectal Neoplasms (Colorectal Cancer)
03/2011 - 04/2008
2
Breast Neoplasms (Breast Cancer)
04/2016 - 01/2016
2
Neoplasms (Cancer)
04/2016 - 01/2012
1
Tics (Tic)
01/2016
1
Cardiotoxicity
01/2016
1
Weight Loss (Weight Reduction)
10/2014
1
Body Weight (Weight, Body)
10/2014
1
Candidiasis (Moniliasis)
01/2012
1
Esophageal Squamous Cell Carcinoma
01/2012
1
Carcinoma (Carcinomatosis)
01/2012
1
Ulcer
08/2008
1
Neoplasm Metastasis (Metastasis)
05/2006
Drug/Important Bio-Agent (IBA)
3
Bevacizumab (Avastin)
FDA Link
12/2010 - 04/2008
2
ErbB Receptors (EGF Receptor)
IBA
03/2011 - 04/2008
2
Oxaliplatin (Eloxatin)
FDA Link
Generic
02/2011 - 04/2008
2
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
08/2008 - 04/2008
1
Ado-Trastuzumab Emtansine
IBA
04/2016
1
zirconium-89-trastuzumab
IBA
04/2016
1
Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)
FDA Link
04/2016
1
Trastuzumab (Herceptin)
FDA Link
01/2016
1
Nitrosamines
IBA
01/2012
1
Magnesium
IBA
02/2011
1
Calcium
IBA
02/2011
1
Cetuximab (Erbitux)
FDA Link
04/2008
1
Capecitabine (Xeloda)
FDA Link
04/2008
Therapy/Procedure
4
Drug Therapy (Chemotherapy)
12/2010 - 04/2008
1
Aftercare (After-Treatment)
10/2014
1
Duration of Therapy
10/2014
1
Adjuvant Chemotherapy
05/2006
1
Neoadjuvant Therapy
05/2006